CLINICAL_TRIALS trial_result · 2022-01-24

Clinical Trial Update: Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19) [Phase 2]

Phase 2 trial assessing CSL312 for adults with COVID-19 has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: CSL Behring | Conditions: Coronavirus Disease 2019 (COVID-19) | Phase 2 | Status: COMPLETED | Results posted: 2022-01-24